Agoston T. Agoston

Brigham and Women's Hospital — United States

Medicine · Health Sciences

23h-index3.2kcitations66works3.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Esophageal Cancer Research and Treatment(29), Gastric Cancer Management and Outcomes(18), Cancer Genomics and Diagnostics(14), Gastrointestinal Tumor Research and Treatment(9), Esophageal and GI Pathology(9)

Publications66 total

Transcriptionally Active Human Papillomavirus Infection in a Minority of Esophageal Squamous Cell Carcinomas in North America
The American Journal of Surgical Pathology·2024· 1 cited
93 IN BARRETT'S ESOPHAGUS, REFLUX INDUCES FEATURES OF EPITHELIAL-MESENCHYMAL PLASTICITY MEDIATED BY APE/REF-1 REDOX FUNCTION: EVIDENCE FROM STUDIES IN BARRETT'S PATIENTS AND ORGANOIDS
Gastroenterology·2024
Hypoxia-inducible factor-1α mediates reflux-induced epithelial-mesenchymal plasticity in Barrett’s oesophagus patients
Gut·2024· 8 citedOpen Access
Genomic signatures of past and present chromosomal instability in Barrett’s esophagus and early esophageal adenocarcinoma
Nature Communications·2023· 27 citedOpen Access
Supplementary Tables 1-8 from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
2023Open Access
Supplementary Methods from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
2023Open Access
Supplementary Figures 1-4 from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
2023Open Access
Data from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
2023Open Access
Supplementary Tables 1-8 from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
2023Open Access
Supplementary Methods from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
2023Open Access
Supplementary Figures 1-4 from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
2023Open Access
Data from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
2023Open Access
Supplementary Figure Legends from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
2023Open Access
Supplementary Figure Legends from Genomic Heterogeneity as a Barrier to Precision Medicine in Gastroesophageal Adenocarcinoma
2023Open Access
Esophageal squamous cell carcinoma with basaloid features are genetically and prognostically similar to conventional squamous cell carcinoma
Modern Pathology·2022· 8 cited
Characterization of twenty-five ovarian tumour cell lines that phenocopy primary tumours
UNC Libraries·2020Open Access
A Rationally Designed ICAM1 Antibody Drug Conjugate for Pancreatic Cancer
Advanced Science·2020· 32 citedOpen Access
Role of submucosal glands in the development and progression of carcinoma in Barrett's oesophagus
Pathology·2020
Magnetic cholecysto-duodenal anastomosis
Minimally Invasive Therapy & Allied Technologies·2019· 2 cited
Loss of SMAD4 protein expression in gastrointestinal and extra‐gastrointestinal carcinomas
Histopathology·2019· 46 cited
page 1 of 4Next →

Frequent Co-authors

Robert D. Odze(21), Amitabh Srivastava(11), Rhonda F. Souza(8), Stuart J. Spechler(8), Gregory Y. Lauwers(8), Matthew D. Stachler(7), Adam J. Bass(7), Katie S. Nason(6), Namrata Setia(6), Thai Pham(6), Aaron R. Thorner(5), Matthew D. Ducar(5), Yu Imamura(5), Qiuyang Zhang(5), Jon M. Davison(4), Eirini Pectasides(4), Sarah Derks(4), Steven B. Maron(4), Mirazul Islam(4), Lindsay Alpert(4)